Author of the publication

Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles

, , , , , , and . Bioconjugate Chemistry, 25 (5): 879--887 (May 2014)
DOI: 10.1021/bc400517j

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity, , , , , , and . Protein Engineering, Design and Selection, 25 (10): 603--612 (October 2012)Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity, , , , , , and . mAbs, (September 2018)Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma, , , , , , , , , and 16 other author(s). Clinical Cancer Research, (November 2018)GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments, and . Molecules, 27 (10): 3272 (2022)Fc-based Duokines : dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc), , , , , , and . OncoImmunology, 11 (1): 2028961 (2022)An optimized antibody-single-chain TRAIL fusion protein for cancer therapy, , , , , , , , , and . mAbs, 8 (5): 879-891 (2016)Superior Properties of Fc-comprising scTRAIL Fusion Proteins, , , , , , , and . Molecular cancer therapeutics, 16 (12): 2792-2802 (2017)Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV, , , , , , , , , and 1 other author(s). mAbs, 9 (5): 831-843 (2017)A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells, , , , and . Scientific reports, (2021)Superior properties of Fc-comprising scTRAIL fusion proteins, , , , , , , and . Molecular Cancer Therapeutics, 16 (12): molcanther.0551.2017 (December 2017)